NASDAQ:ICUI - ICU Medical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $265.75 -1.10 (-0.41 %) (As of 09/20/2018 04:00 PM ET)Previous Close$266.85Today's Range$265.50 - $269.2552-Week Range$180.40 - $321.70Volume166,000 shsAverage Volume151,900 shsMarket Capitalization$5.53 billionP/E Ratio48.14Dividend YieldN/ABeta0.36 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV solutions, such as normal salines, ringers, etc., which are used to replenish fluids and electrolytes; irrigation solutions to hydrate the wound, remove deep debris, assist with visual examination, to prevent infection, and improve healing; and nutritional solutions that feed vitamins, minerals, and other natural therapeutic substances directly into the blood stream. In addition, the company offers infusion pumps under the Plum 360, LifeCare PCA, SapphirePlus, and Sapphire names; Cogent 2-in-1 and LiDCO LX1 hemodynamic monitoring systems; CardioFlo hemodynamic monitoring sensors; TriOx PICC invasive venous oximetry sensors; SafeSet closed blood sampling and conservation systems; Transpac consumable blood pressure transducers; and Q2 Plus continuous cardiac output/oximetry systems. The company sells its products primarily to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California. Receive ICUI News and Ratings via Email Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies SectorMedical SymbolNASDAQ:ICUI CUSIP44930G10 Webwww.icumed.com Phone949-366-2183 Debt Debt-to-Equity RatioN/A Current Ratio4.44 Quick Ratio3.02 Price-To-Earnings Trailing P/E Ratio48.14 Forward P/E Ratio34.97 P/E GrowthN/A Sales & Book Value Annual Sales$1.29 billion Price / Sales4.21 Cash Flow$8.8939 per share Price / Cash29.88 Book Value$59.52 per share Price / Book4.46 Profitability EPS (Most Recent Fiscal Year)$5.52 Net Income$68.64 million Net Margins5.93% Return on Equity12.78% Return on Assets10.22% Miscellaneous Employees6,802 Outstanding Shares20,470,000Market Cap$5.53 billion ICU Medical (NASDAQ:ICUI) Frequently Asked Questions What is ICU Medical's stock symbol? ICU Medical trades on the NASDAQ under the ticker symbol "ICUI." How were ICU Medical's earnings last quarter? ICU Medical, Incorporated (NASDAQ:ICUI) issued its quarterly earnings results on Thursday, August, 9th. The medical instruments supplier reported $2.66 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.82 by $0.84. The medical instruments supplier had revenue of $360.46 million for the quarter, compared to analyst estimates of $337.60 million. ICU Medical had a net margin of 5.93% and a return on equity of 12.78%. The business's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.76 earnings per share. View ICU Medical's Earnings History. When is ICU Medical's next earnings date? ICU Medical is scheduled to release their next quarterly earnings announcement on Thursday, November, 8th 2018. View Earnings Estimates for ICU Medical. What guidance has ICU Medical issued on next quarter's earnings? ICU Medical updated its FY18 earnings guidance on Thursday, August, 9th. The company provided earnings per share guidance of $8.30-8.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.58. Who are some of ICU Medical's key competitors? Some companies that are related to ICU Medical include ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Insulet (PODD), Hill-Rom (HRC), Haemonetics (HAE), Integra Lifesciences (IART), Penumbra (PEN), Globus Medical (GMED), Novocure (NVCR), Cantel Medical (CMD), NuVasive (NUVA), Merit Medical Systems (MMSI) and Tandem Diabetes Care (TNDM). Who are ICU Medical's key executives? ICU Medical's management team includes the folowing people: Mr. Vivek Jain, Chairman & CEO (Age 46)Mr. Scott E. Lamb, CFO & Treasurer (Age 55)Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 60)Ms. Alison D. Burcar, Corp. VP of Product Strategy for IV Consumables (Age 45)Mr. Steven C. Riggs, Exec. Officer of Special Project Opertions (Age 59) Has ICU Medical been receiving favorable news coverage? Press coverage about ICUI stock has trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ICU Medical earned a daily sentiment score of 0.18 on Accern's scale. They also gave news coverage about the medical instruments supplier an impact score of 46.57 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future. View Recent Headlines for ICU Medical. Who are ICU Medical's major shareholders? ICU Medical's stock is owned by many different of retail and institutional investors. Top institutional investors include Janus Henderson Group PLC (6.71%), BlackRock Inc. (6.51%), Wells Fargo & Company MN (2.16%), Renaissance Technologies LLC (1.54%), Dimensional Fund Advisors LP (1.13%) and OppenheimerFunds Inc. (1.11%). Company insiders that own ICU Medical stock include Alison D Burcar, Daniel Woolson, George A Lopez, Joseph R Saucedo, Pfizer Inc, Richard Md Sherman, Robert S Swinney, Scott E Lamb, Steven Riggs, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain. View Institutional Ownership Trends for ICU Medical. Which institutional investors are selling ICU Medical stock? ICUI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Northern Trust Corp, Dimensional Fund Advisors LP, Rothschild Asset Management Inc., Public Employees Retirement Association of Colorado, Gamco Investors INC. ET AL, Eagle Asset Management Inc. and Point72 Asset Management L.P.. Company insiders that have sold ICU Medical company stock in the last year include Alison D Burcar, Daniel Woolson, George A Lopez, Joseph R Saucedo, Pfizer Inc, Robert S Swinney, Scott E Lamb, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain. View Insider Buying and Selling for ICU Medical. Which institutional investors are buying ICU Medical stock? ICUI stock was purchased by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Federated Investors Inc. PA, Cornerstone Wealth Management LLC, Paloma Partners Management Co, Smith Asset Management Group LP, Canada Pension Plan Investment Board, DE Burlo Group Inc. and Citadel Advisors LLC. View Insider Buying and Selling for ICU Medical. How do I buy shares of ICU Medical? Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is ICU Medical's stock price today? One share of ICUI stock can currently be purchased for approximately $265.75. How big of a company is ICU Medical? ICU Medical has a market capitalization of $5.53 billion and generates $1.29 billion in revenue each year. The medical instruments supplier earns $68.64 million in net income (profit) each year or $5.52 on an earnings per share basis. ICU Medical employs 6,802 workers across the globe. How can I contact ICU Medical? ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected] MarketBeat Community Rating for ICU Medical (NASDAQ ICUI)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 257 (Vote Outperform)Underperform Votes: 252 (Vote Underperform)Total Votes: 509MarketBeat's community ratings are surveys of what our community members think about ICU Medical and other stocks. Vote "Outperform" if you believe ICUI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICUI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/20/2018 by MarketBeat.com StaffFeatured Article: How much money do you need to begin day trading?